220100 — FutureChem Co Income Statement

0.000.00%

Last trade - 00:00

HealthcareHighly SpeculativeSmall CapSucker Stock

Annual income statement for FutureChem Co, fiscal year end - December 31st, KRW millions except per share, conversion factor applied.

	2020 December 31st	2021 December 31st	2022 December 31st	2023 December 31st	2024 December 31st
Period Length:	12 M	12 M	12 M	12 M	12 M
Source:	Annual Audited Accounts	Annual Audited Accounts	Annual Audited Accounts	Annual Audited Accounts	Annual Audited Accounts
Standards:	IFRS	IFRS	IFRS	IFRS	IFRS
Status:	Final	Final	Final	Final	Final
Revenue
Total Revenue	11,013	11,818	12,574	13,968	17,293
Cost of Revenue
Gross Profit	2,840	2,497	1,710	1,569	3,024
Selling / General / Administrative Expenses
Research And Development
Depreciation and Amortization
Unusual Expense / Income
Total Operating Expenses	15,980	19,719	25,508	22,380	26,761
Operating Profit	-4,967	-7,901	-12,934	-8,412	-9,467
Gain / Loss on Sale of Assets
Total Net Non Operating Interest Income / Expense
Other Net Non Operating Costs
Net Income Before Taxes	-23,194	-3,464	-14,007	-6,701	-9,396
Provision for Income Taxes
Net Income After Taxes	-23,194	-3,464	-14,011	-6,712	-9,425
Minority Interest
Net Income Before Extraordinary Items
Net Income	-23,101	-3,420	-13,959	-6,709	-9,418
Income Available to Common Shareholders Excluding Extraordinary Items
Income Available to Common Shareholders Including Extraordinary Items
Diluted Net Income	-23,101	-3,420	-13,959	-6,709	-9,418
Diluted Weighted Average Shares
Basic EPS Including Extraordinary Items
Diluted EPS Including Extraordinary Items
Diluted EPS Excluding Extraordinary Items
Normalised Income Before Taxes
Normalised Income After Taxes
Normalised Income Available to Common Shareholders
Diluted Normalised EPS	-1,743	-178	-732	-304	-396
Dividends per Share